BAPI gets new committee

Abdul Mukadir, Chairman and Managing Director of Incepta Pharmaceuticals Ltd., has been elected President of the Bangladesh Association of Pharmaceutical Industries (BAPI) for a two-year term.

The election also saw Dr Md Zakir Hossain, Managing Director of Delta Pharma Ltd., elected Secretary General, and Muhammad Halimuzzaman, Deputy Managing Director & CEO of Healthcare Pharmaceuticals Ltd., elected Treasurer. These appointments will cover the 2025-2026 and 2026-2027 terms.

Furthermore, M Mosaddek Hossain, Chairman of UNIMADE UNIHEALTH Pharmaceuticals Ltd., was elected Senior Vice-President, and S Kaiser Kabir, Managing Director & CEO of RENATA PLC, was elected Vice-President.

The 54th Annual General Meeting of BAPI was held on 15 March, where the election for the new executive committee took place.

The newly elected 20-member executive committee includes S M Shafiuzzaman (managing director, Hudson Pharmaceuticals Ltd), Md Harunur Rashid (chairman and managing director, Globe Pharmaceuticals Ltd), MA Haider Hussain (managing director, Drug International Ltd), Rabbur Reza (CEO, Senevia Pharma PLC), Hasnin Muktadir (vice chairman, Incepta Pharmaceuticals Ltd - Vaccine Division), Md Abdur Razzaq (managing director, Nipro JMI Pharma Ltd.), Simeen Rahman (managing director and group CEO, SKF Pharmaceuticals Ltd), M Mohibuz Zaman (chief operating officer, ACI Ltd), Md Nasser Shahriar Zahedi (chairman, Radiant Pharmaceuticals Ltd), KSM Mostafizur Rahman (managing director, One Pharma Ltd), Md Mizanur Rahman (Executive Director, Square Pharmaceuticals Ltd - Chemical Division), Fahim Sinha (Director, The ACME Laboratories Ltd), Ahmed Imtiaz Hassan (director, Aristopharma Ltd), Rafidul Haq (managing director, General Pharmaceuticals Ltd - Unit-2), and Arafat Zahid Ibn Shafi (deputy managing director, Minara API Ltd).